Risk of health status worsening in primary infertile men: a prospective 10-year follow-up study.

A severe male infertility factor has been associated with both lower health status and increased mortality in infertile men.

To investigate reproductive factors associated with health status impairment in infertile men over a 10-year time frame since first clinical evaluation.

Data from 899 infertile men were analysed at baseline between 2003 and 2010. Health-significant comorbidities were scored with the Charlson Comorbidity Index (CCI). Patients were followed-up yearly recording any worsening in their health status until 2019. Cox regression models were used to estimate hazard ratios (HR) and 95% confidence intervals (CI) of CCI score increase.

At a median follow-up of 136 months (IQR 121, 156), 85 men (9.5%) depicted an increase of their baseline CCI score of at least 1 point. The most frequent reason for CCI upgrade was cancer (34%), cardio-vascular diseases (29%) and diabetes mellitus (22%). Compared to patients without a CCI increase, patients with a CCI increase presented with higher BMI and FSH values, a higher rate of baseline CCI ≥ 1 (all p < 0.01) and a greater proportion of non-obstructive azoospermia (p < 0.001). In the Cox regression model, patient's BMI (p < 0.001), baseline CCI ≥ 1 (p < 0.01) and azoospermia status (p = 0.001) were found to be independently associated with CCI increases.

Almost 10% of men presenting for primary infertility had a decrease of the overall health status already in the relatively short 10-year time frame after first presentation. Non-obstructive azoospermic men showed the worst health status impairment and should be strictly followed-up regardless of their fertility status. This article is protected by copyright. All rights reserved.

Andrology. 2021 Aug 09 [Epub ahead of print]

Luca Boeri, Eugenio Ventimiglia, Walter Cazzaniga, Filippo Pederzoli, Giueppe Fallara, Edoardo Pozzi, Federico Belladelli, Andrea Baudo, Nicola Frego, Paolo Capogrosso, Massimo Alfano, Francesco Montorsi, Andrea Salonia

Division of Experimental Oncology/Unit of Urology, URI; IRCCS Ospedale San Raffaele, Milan, Italy.